Brain training may delay dementia in At-Risk seniors

NCT ID NCT04792528

Ongoing Disease control Sponsor: Sorlandet Hospital HF Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether computerized memory training can slow mental decline in people with mild cognitive impairment (MCI), a stage between normal aging and dementia. About 205 participants from Norwegian memory clinics will do brain exercises on a computer or play a simple game (control group). Researchers will track memory, daily function, and quality of life for up to 4 years to see if training helps delay dementia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: computerized cognitive training (COGMED RM program)
What this could lead to: If it works, this could offer a non-drug way to delay dementia in people with mild cognitive impairment, potentially improving quality of life and reducing healthcare costs.
What could go wrong: This is an early-stage study with 205 participants, so results may not apply to everyone. The training may not slow decline, and benefits could be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MILD COGNITIVE IMPAIRMENT

Contacts and locations

Locations

N.K.S. Kløveråsen

Bodø, 8076, Norway
NKS Olaviken Alderspsykiatriske sykehus - Hukommelsesklinikk

Bergen, 5009, Norway
Oslo Universitetssykehus Ullevål

Oslo, Norway
St. Olavs Hospital

Trondheim, 7006, Norway
Sørlandet Sykehus Arendal

Arendal, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.